Notify me when Silver Point Capital L.P. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 21 | $2,219,032,855 | +$444,197,239 | -$428,865,345 | +$15,331,894 | GPOR, ECHOSTAR CORP, AERO, IAU, JD.COM INC | 13F-HR | 17 Feb 2026, 17:08 |
| Q3 2025 | 23 | $1,925,857,269 | +$812,293,148 | -$922,579,334 | -$110,286,186 | GPOR, ECHOSTAR CORP, JD.COM INC, MSC, IAU | 13F-HR | 14 Nov 2025, 16:10 |
| Q2 2025 | 16 | $1,424,806,188 | +$561,285,423 | -$243,361,734 | +$317,923,689 | GPOR, ECHOSTAR CORP, SATS, USHY, MSC | 13F-HR | 14 Aug 2025, 16:23 |
| Q1 2025 | 11 | $1,048,044,383 | +$211,205,885 | -$124,203,307 | +$87,002,578 | GPOR, ECHOSTAR CORP, SGI, MSC, TDS | 13F-HR | 15 May 2025, 16:23 |
| Q4 2024 | 11 | $1,000,678,139 | +$152,420,029 | -$273,197,916 | -$120,777,887 | GPOR, MSC, ECHOSTAR CORP, TDS, DHC | 13F-HR | 14 Feb 2025, 16:04 |
| Q3 2024 | 8 | $1,065,486,877 | +$50,767,680 | -$258,986,719 | -$208,219,039 | GPOR, MSC, DHC, SATS, MPW | 13F-HR | 14 Nov 2024, 16:24 |
| Q2 2024 | 11 | $1,179,950,185 | +$88,030,044 | -$89,763,112 | -$1,733,068 | GPOR, MSC, FYBR, SATS, DHC | 13F-HR | 14 Aug 2024, 16:10 |
| Q1 2024 | 10 | $1,250,052,276 | +$109,337,862 | -$124,937,724 | -$15,599,862 | GPOR, MSC, FYBR, PELOTON INTERACTIVE INC, DHC | 13F-HR | 15 May 2024, 13:21 |
| Q4 2023 | 10 | $1,120,705,758 | +$20,666,793 | -$208,776,585 | -$188,109,792 | GPOR, MSC, FYBR, DHC, PR | 13F-HR | 14 Feb 2024, 16:06 |
| Q3 2023 | 13 | $1,108,761,810 | +$159,229,671 | -$244,892,980 | -$85,663,309 | GPOR, MSC, FYBR, DHC, PR | 13F-HR | 14 Nov 2023, 16:09 |
| Q2 2023 | 7 | $1,160,427,564 | +$120,524,398 | -$264,373,616 | -$143,849,218 | GPOR, MSC, DEN, FYBR, KRE | 13F-HR | 14 Aug 2023, 16:05 |
| Q1 2023 | 6 | $1,105,466,553 | $0 | -$125,346,005 | -$125,346,005 | GPOR, MSC, FYBR, PCG, DEN | 13F-HR | 15 May 2023, 17:02 |
| Q4 2022 | 8 | $1,191,541,472 | +$22,037,542 | -$189,372,393 | -$167,334,851 | GPOR, FYBR, MSC, PCG, DEN | 13F-HR | 14 Feb 2023, 16:06 |
| Q3 2022 | 9 | $1,344,911,000 | +$21,462,779 | -$224,647,918 | -$203,185,139 | GPOR, FYBR, DEN, MSC, PCG | 13F-HR | 14 Nov 2022, 16:50 |
| Q2 2022 | 9 | $1,281,152,000 | +$1,439,758 | -$230,240,259 | -$228,800,501 | GPOR, DEN, FYBR, PCG, IHRT | 13F-HR | 15 Aug 2022, 17:23 |
| Q1 2022 | 14 | $1,986,676,000 | +$277,152,609 | -$255,838,039 | +$21,314,570 | GPOR, DEN, FYBR, PCG, MSC | 13F-HR | 16 May 2022, 16:08 |
| Q4 2021 | 13 | $1,833,093,000 | +$42,008,597 | -$241,101,367 | -$199,092,770 | GPOR, PCG, DEN, FYBR, IHRT | Restatement | 18 Feb 2022, 16:34 |
| Q3 2021 | 12 | $2,102,965,000 | +$288,285,355 | -$88,830,794 | +$199,454,561 | GPOR, PCG, FYBR, DEN, IHRT | 13F-HR | 15 Nov 2021, 16:28 |
| Q2 2021 | 13 | $1,825,082,000 | +$840,242,761 | -$69,332,158 | +$770,910,603 | GPOR, DEN, PCG, FYBR, MSC | 13F-HR | 16 Aug 2021, 16:21 |
| Q1 2021 | 12 | $948,390,000 | +$282,351,963 | -$210,033,776 | +$72,318,187 | PCG, MSC, DEN, IHRT, INTERCEPT PHARMACEUTICALS IN | Restatement | 23 Jun 2021, 16:46 |
| Q4 2020 | 11 | $861,623,000 | +$113,590,132 | -$156,501,539 | -$42,911,407 | PCG, MSC, PDLI, FE, INTERCEPT PHARMACEUTICALS IN | 13F-HR | 16 Feb 2021, 16:16 |
| Q3 2020 | 12 | $819,824,000 | +$238,746,868 | -$157,224,781 | +$81,522,087 | PCG, MSC, CZR, FE, PDLI | 13F-HR | 16 Nov 2020, 16:04 |
| Q2 2020 | 9 | $708,631,000 | +$177,086,915 | -$311,481,015 | -$134,394,100 | PCG, MSC, CZR, ERI, PDLI | 13F-HR | 14 Aug 2020, 16:16 |
| Q1 2020 | 17 | $827,629,000 | +$325,003,315 | -$9,302,740 | +$315,700,575 | MSC, PCG, VCIT, LQD, MUB | 13F-HR | 14 May 2020, 16:58 |
| Q4 2019 | 8 | $724,765,000 | +$87,734,413 | -$114,395,860 | -$26,661,447 | PCG, MSC, ERI, CZR, ROCC | 13F-HR | 14 Feb 2020, 15:00 |
| Q3 2019 | 12 | $670,905,000 | +$96,997,980 | -$22,537,834 | +$74,460,146 | MSC, PCG, CZR, ERI, CMLS | 13F-HR | 14 Nov 2019, 16:14 |
| Q2 2019 | 10 | $804,852,000 | +$109,066,516 | -$157,459,886 | -$48,393,370 | PCG, MSC, CZR, ERI, CMLS | 13F-HR | 14 Aug 2019, 16:06 |
| Q1 2019 | 12 | $711,144,000 | +$224,091,193 | -$261,596,296 | -$37,505,103 | PCG, MSC, CZR, CMLS, CAESARS ENTMT CORP | 13F-HR | 15 May 2019, 16:16 |
| Q4 2018 | 14 | $691,381,000 | +$226,618,497 | -$195,852,874 | +$30,765,623 | CZR, MSC, VICI, CAESARS ENTMT CORP, PCG | 13F-HR | 14 Feb 2019, 16:11 |
| Q3 2018 | 13 | $938,257,000 | +$246,157,139 | -$273,238,887 | -$27,081,748 | VICI, CZR, CHAPQ, PCG, CAESARS ENTMT CORP | 13F-HR | 14 Nov 2018, 16:21 |
| Q2 2018 | 11 | $982,244,000 | +$54,092,694 | -$221,354,993 | -$167,262,299 | VICI, CZR, QCP, CPS, CAESARS ENTMT CORP | 13F-HR | 14 Aug 2018, 16:38 |
| Q1 2018 | 13 | $1,093,377,000 | +$311,961,336 | -$131,291,198 | +$180,670,138 | VICI, CZR, QCP, NPO, CPS | 13F-HR | 15 May 2018, 16:37 |
| Q4 2017 | 15 | $971,344,000 | +$313,119,685 | -$307,047,727 | +$6,071,958 | CZR, NPO, CPS, QCP, BASXQ | 13F-HR | 14 Feb 2018, 17:12 |
| Q3 2017 | 16 | $911,821,000 | +$153,014,135 | -$199,681,496 | -$46,667,361 | NPO, IWM, CPS, QCP, BASXQ | 13F-HR | 14 Nov 2017, 17:16 |
| Q2 2017 | 20 | $936,171,000 | +$116,886,806 | -$298,345,190 | -$181,458,384 | CPS, NPO, BASXQ, QCP, ALLY | 13F-HR | 14 Aug 2017, 16:42 |
| Q1 2017 | 23 | $1,168,995,000 | +$412,016,319 | -$157,697,750 | +$254,318,569 | CPS, BASXQ, SPY, NPO, IWM | 13F-HR | 15 May 2017, 16:03 |
| Q4 2016 | 20 | $912,486,000 | +$367,945,446 | -$168,500,856 | +$199,444,590 | CPS, BASXQ, NPO, ALLY, PHH | 13F-HR | 14 Feb 2017, 12:18 |
| Q3 2016 | 14 | $669,101,000 | +$17,402,340 | -$272,869,199 | -$255,466,859 | CPS, AIG, NPO, PHH, ALLY | 13F-HR | 14 Nov 2016, 17:40 |
| Q2 2016 | 16 | $803,946,000 | +$110,946,120 | -$148,703,047 | -$37,756,927 | CPS, AIG, NPO, PHH, NTK | 13F-HR | 15 Aug 2016, 17:02 |
| Q1 2016 | 17 | $803,759,000 | +$135,198,784 | -$100,432,405 | +$34,766,379 | CPS, AIG, NPO, HYG, BLD | 13F-HR | 16 May 2016, 17:03 |
| Q4 2015 | 15 | $795,450,000 | +$75,916,368 | -$128,740,378 | -$52,824,010 | CPS, AIG, NPO, BLD, AIGWS | 13F-HR | 16 Feb 2016, 16:42 |
| Q3 2015 | 17 | $775,478,000 | +$109,430,272 | -$103,300,339 | +$6,129,933 | CPS, AIG, BLD, NPO, NTK | 13F-HR | 16 Nov 2015, 17:03 |
| Q2 2015 | 17 | $915,024,000 | +$103,071,646 | -$167,940,114 | -$64,868,468 | CPS, AIG, NPO, NTK, DAN | 13F-HR | 14 Aug 2015, 17:01 |
| Q1 2015 | 16 | $949,864,000 | +$37,611,319 | -$164,499,849 | -$126,888,530 | CPS, AIG, NPO, NTK, DAN | 13F-HR | 15 May 2015, 17:20 |
| Q4 2014 | 19 | $1,052,181,000 | +$80,194,582 | -$125,652,300 | -$45,457,718 | CPS, AIG, DAN, NPO, NTK | 13F-HR | 17 Feb 2015, 15:31 |
| Q3 2014 | 21 | $1,060,753,000 | +$199,333,089 | -$237,343,460 | -$38,010,371 | AIG, CPS, DAN, NPO, NTK | 13F-HR | 14 Nov 2014, 17:02 |
| Q2 2014 | 22 | $1,159,495,000 | +$204,812,044 | -$223,081,008 | -$18,268,964 | AIG, CPS, NPO, CNP, NTK | 13F-HR | 14 Aug 2014, 17:00 |
| Q1 2014 | 30 | $1,153,019,000 | +$117,498,207 | -$284,758,849 | -$167,260,642 | AIG, CPS, ETFC, HMHC, DOOR | 13F-HR | 15 May 2014, 17:01 |
| Q4 2013 | 31 | $1,210,456,000 | $0 | $0 | $0 | AIG, CPS, 3106PS, ETFC, DOOR | 13F-HR | 14 Feb 2014, 16:34 |